医療法人 笑顔会 NexWel銀座ひざ関節症クリニック
Explore the institution's name, address and registered technologies as published, along with plan classifications, score components and sources.
The ranking reflects only the registration data published by Japan's Ministry of Health, Labour and Welfare; it does not represent treatment outcomes or quality of care. Scoring method →
Source: Ministry of Health, Labour and Welfare public directory of regenerative medicine providers MHLW e-Regenerative Medicine public register · Directory archive date I: 2026-07-19 / II: 2026-09-26 / III: 2026-05-18 · Internet Archive
01C2012018 +3Location
- Prefecture
- Tokyo
- Address
- 中央区銀座7-8-13 Brown Place 5F
Plan classification
- Class INot registered
- Class IIThe medium-risk category under the law.
- Class IIIThe low-risk category under the law.
Certified committee for regenerative medicine
- 安全未来特定認定再生医療等委員会
- 医療法人清悠会認定再生医療等委員会
Public score
56.4/ 100
- A · Review level
- 25.0 / 30
- B · Technologies
- 18.5 / 35
- C · Coverage
- 7.1 / 25
- D · Class I / II technologies
- 5.8 / 10
The public score is calculated from public registration information and does not reflect quality of care. Scoring method →
Registered technologies (4)
Stem cells (all sources) 3
| Registered technologies · Japanese original | Technology areas | Plan classification |
|---|---|---|
| 自己脂肪由来間葉系幹細胞を用いた脳卒中後遺症に対する治療 | Stem cells (all sources)Adipose-derived stem cells | Class II |
| 自己骨髄由来間葉系幹細胞を用いた脊髄損傷治療 | Stem cells (all sources)Bone marrow-derived | Class II |
| 自己脂肪由来間葉系幹細胞を用いた脊髄損傷治療 | Stem cells (all sources)Adipose-derived stem cells | Class II |
Adipose-derived stem cells 2
| Registered technologies · Japanese original | Technology areas | Plan classification |
|---|---|---|
| 自己脂肪由来間葉系幹細胞を用いた脳卒中後遺症に対する治療 | Stem cells (all sources)Adipose-derived stem cells | Class II |
| 自己脂肪由来間葉系幹細胞を用いた脊髄損傷治療 | Stem cells (all sources)Adipose-derived stem cells | Class II |
Bone marrow-derived 1
| Registered technologies · Japanese original | Technology areas | Plan classification |
|---|---|---|
| 自己骨髄由来間葉系幹細胞を用いた脊髄損傷治療 | Stem cells (all sources)Bone marrow-derived | Class II |
NK and immune cells 1
| Registered technologies · Japanese original | Technology areas | Plan classification |
|---|---|---|
| NKTがんワクチンGC-MO(α-Galactosylceramideパルスヒト自家CD14陽性細胞)を用いたiNKTがん治療 | NK and immune cells | Class III |
Certified committee for regenerative medicine
- 安全未来特定認定再生医療等委員会
- 医療法人清悠会認定再生医療等委員会
Public document number
01C201201801C201102701C201201902C2103024
Plan classification · Certified committee for regenerative medicine · Public document number
| Registered technologies | Plan classification | Certified committee for regenerative medicine | Public document number |
|---|---|---|---|
| 自己脂肪由来間葉系幹細胞を用いた脳卒中後遺症に対する治療 | Class II | 安全未来特定認定再生医療等委員会 | 01C2012018 |
| 自己骨髄由来間葉系幹細胞を用いた脊髄損傷治療 | Class II | 安全未来特定認定再生医療等委員会 | 01C2011027 |
| 自己脂肪由来間葉系幹細胞を用いた脊髄損傷治療 | Class II | 安全未来特定認定再生医療等委員会 | 01C2012019 |
| NKTがんワクチンGC-MO(α-Galactosylceramideパルスヒト自家CD14陽性細胞)を用いたiNKTがん治療 | Class III | 医療法人清悠会認定再生医療等委員会 | 02C2103024 |
Other institutions in the same prefecture
- 東邦大学医療センター大森病院Public score 56.4
- NAG整形外科Public score 56.2
- SBC整形外科クリニック 西新宿本院Public score 56.2
- 医療法人社団 TSOC 東京スポーツ&整形外科クリニック北参道Public score 56.2
- 医療法人社団 郁栄会 銀座エルディアクリニックPublic score 56.2
- 医療法人社団 苑田会 苑田会人工関節センター病院Public score 56.2
- 医療法人社団 福至会 SPES CLINIC TOKYO BAY 晴海中央医院Public score 56.2
- 医療法人社団下田緑眞会 世田谷北部病院Public score 56.2